D-0065-2021 Class III Terminated

Recalled by Aurobindo Pharma USA Inc. — East Windsor, NJ

FDA drug recall D-0065-2021 was initiated by Aurobindo Pharma USA Inc. on Oct 22, 2020 and is designated Class III. Reason for recall: Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups. The recall status is terminated (terminated Apr 4, 2023). Affected quantity: 7440 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 11, 2020
Initiation Date
Oct 22, 2020
Termination Date
Apr 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7440 bottles

Product description

Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever Reducer, 4 fl oz (120 mL), Berry Flavor, Distributed by Chalkboard Health Inc. Princeton, NJ 08540 getfluenthealth.com Made in India. NDC 79395-003-92

Reason for recall

Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.

Distribution pattern

NJ

Code information

Lot # BO1020080AA3, EXP 7/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0065-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0065-2021. Report a data issue: hello@regdatalab.com.